The Centre for Eye Research of Victoria, in Australia, has received a grant of 497,000 Australian dollars (€402,000-$500,000) to conduct clinical trials intended to prove that a new nanosecond laser technology developed in Australia can be effectively used to slow down the progression of age-related macular degeneration (AMD). The theory ...
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
Or sign-up for a trial month for just 9,90€. To continue reading this article register now.